Neuropace
NPCE
NASDAQ
IPO2021
about NPCE
Neuropace is a medical technology company that develops and manufactures advanced neural monitoring systems for use in neurosurgical procedures.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $9.34 | $9.55 | $9.23 | $310.97M | 296.46K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.26 | n/a | 16.00 | -29.01% | -36.78% | 0% |